Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells

  • Park, Sang-Min; 
  • Hwang, Chae Young; 
  • Cho, Sung-Hwan; 
  • Lee, Daewon; 
  • Gong, Jeong-Ryeol; 
  • 외 3명
Citations

WEB OF SCIENCE

37
Citations

SCOPUS

40

초록

Cetuximab (CTX), a monoclonal antibody against epidermal growth factor receptor, is being widely used for colorectal cancer (CRC) with wild-type (WT) KRAS. However, its responsiveness is still very limited and WT KRAS is not enough to indicate such responsiveness. Here, by analyzing the gene expression data of CRC patients treated with CTX monotherapy, we have identified DUSP4, ETV5, GNB5, NT5E, and PHLDA1 as potential targets to overcome CTX resistance. We found that knockdown of any of these five genes can increase CTX sensitivity in KRAS WT cells. Interestingly, we further found that GNB5 knockdown can increase CTX sensitivity even for KRAS mutant cells. We unraveled that GNB5 overexpression contributes to CTX resistance by modulating the Akt signaling pathway from experiments and mathematical simulation. Overall, these results indicate that GNB5 might be a promising target for combination therapy with CTX irrespective of KRAS mutation.

키워드

cetuximab; colorectal cancer; drug resistance; mathematical modeling; systems biology; G-PROTEIN; DRUG-RESISTANCE; DYNAMICS; KRAS; EXPRESSION; MECHANISMS; THERAPIES; EFFICACY; BIOLOGY; BIOCONDUCTOR
제목
Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells
저자
Park, Sang-Min; Hwang, Chae Young; Cho, Sung-Hwan; Lee, Daewon; Gong, Jeong-Ryeol; Lee, Soobeom; Nam, Sohee; Cho, Kwang-Hyun
DOI
10.1111/febs.14773
발행일
2019-04
유형
Article
저널명
FEBS Journal
권
286
호
7
페이지
1305 ~ 1318